标题
Innate immunity, cytokine storm, and inflammatory cell death in COVID-19
作者
关键词
-
出版物
Journal of Translational Medicine
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-11-23
DOI
10.1186/s12967-022-03767-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prognostic impact of toll-like receptors gene polymorphism on outcome of COVID-19 pneumonia: A case-control study
- (2022) Mahmoud M. Alseoudy et al. CLINICAL IMMUNOLOGY
- TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS‐CoV‐2 infection
- (2022) Renée M. van der Sluis et al. EMBO JOURNAL
- Interferon-γ primes macrophages for pathogen ligand-induced killing via a caspase-8 and mitochondrial cell death pathway
- (2022) Daniel S. Simpson et al. IMMUNITY
- Human genetic and immunological determinants of critical COVID-19 pneumonia
- (2022) Qian Zhang et al. NATURE
- The cGAS–STING pathway drives type I IFN immunopathology in COVID-19
- (2022) Jeremy Di Domizio et al. NATURE
- Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
- (2022) Chansavath Phetsouphanh et al. NATURE IMMUNOLOGY
- Innate immunity: the first line of defense against SARS-CoV-2
- (2022) Michael S. Diamond et al. NATURE IMMUNOLOGY
- Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection
- (2022) Hadas Tamir et al. Viruses-Basel
- SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
- (2022) Christopher J. Neufeldt et al. Communications Biology
- FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
- (2022) Caroline Junqueira et al. NATURE
- Caspase-4/11 exacerbates disease severity in SARS–CoV-2 infection by promoting inflammation and immunothrombosis
- (2022) Mostafa M. Eltobgy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The immunology and immunopathology of COVID-19
- (2022) Miriam Merad et al. SCIENCE
- SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway
- (2022) Huanzhou Xu et al. VIROLOGY
- STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS)
- (2022) Yasmine Messaoud-Nacer et al. Cell Death & Disease
- Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study
- (2022) Daniel Ayoubkhani et al. BMJ-British Medical Journal
- It’s All in the PAN: Crosstalk, Plasticity, Redundancies, Switches, and Interconnectedness Encompassed by PANoptosis Underlying the Totality of Cell Death-Associated Biological Effects
- (2022) Jessica M. Gullett et al. Cells
- ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection
- (2022) Rajendra Karki et al. Science Immunology
- Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
- (2022) Qian Zhang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options
- (2022) Mariem Znaidia et al. Viruses-Basel
- PANoptosis: A Unique Innate Immune Inflammatory Cell Death Modality
- (2022) Nagakannan Pandian et al. JOURNAL OF IMMUNOLOGY
- MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells
- (2021) Xin Yin et al. Cell Reports
- Intestinal host response to SARS-CoV-2 infection and COVID-19 outcomes in patients with gastrointestinal symptoms
- (2021) Alexandra E. Livanos et al. GASTROENTEROLOGY
- Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia
- (2021) Emanuele Pontali et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO
- (2021) Jing Wu et al. Cell Reports
- An open label trial of anakinra to prevent respiratory failure in COVID-19
- (2021) Evdoxia Kyriazopoulou et al. eLife
- Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) François-Xavier Lescure et al. Lancet Respiratory Medicine
- Leveraging systems biology for predicting modulators of inflammation in patients with COVID-19
- (2021) Sascha Jung et al. Science Advances
- SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway
- (2021) Grant R. Campbell et al. iScience
- SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
- (2021) André C. Ferreira et al. Cell Death Discovery
- Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia
- (2021) Daniel Asarnow et al. CELL
- SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination
- (2021) Zhengrong Zhang et al. CELL DEATH AND DIFFERENTIATION
- SARS-CoV-2 spike protein interacts with and activates TLR41
- (2021) Yingchi Zhao et al. CELL RESEARCH
- COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
- (2021) Rebecca Forman et al. HEALTH POLICY
- SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2
- (2021) Qiao Lu et al. IMMUNITY
- SARS‐CoV‐2 ORF9b antagonizes type I and III interferons by targeting multiple components of the RIG‐I/MDA‐5–MAVS, TLR3–TRIF, and cGAS–STING signaling pathways
- (2021) Lulu Han et al. JOURNAL OF MEDICAL VIROLOGY
- Activation of STING signaling pathway effectively blocks human coronavirus infection
- (2021) Wei Liu et al. JOURNAL OF VIROLOGY
- Diverse Functional Autoantibodies in Patients with COVID-19
- (2021) Eric Y. Wang et al. NATURE
- COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets
- (2021) Toni M. Delorey et al. NATURE
- Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
- (2021) Luca Braga et al. NATURE
- TLR2 senses the SARS-CoV-2 envelope protein to produce inflammatory cytokines
- (2021) Min Zheng et al. NATURE IMMUNOLOGY
- RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells
- (2021) Taisho Yamada et al. NATURE IMMUNOLOGY
- Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
- (2021) Prasanna Jagannathan et al. Nature Communications
- IFN-γ and TNF-α drive a CXCL10+ CCL2+ macrophage phenotype expanded in severe COVID-19 lungs and inflammatory diseases with tissue inflammation
- (2021) Fan Zhang et al. Genome Medicine
- SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
- (2021) David W Sanders et al. eLife
- SARS-CoV-2 Membrane Protein Inhibits Type I Interferon Production Through Ubiquitin-Mediated Degradation of TBK1
- (2021) Liyan Sui et al. Frontiers in Immunology
- ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity
- (2021) GuanQun Liu et al. Nature Microbiology
- A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection
- (2021) Fiachra Humphries et al. Science Immunology
- Pharmacological activation of STING blocks SARS-CoV-2 infection
- (2021) Minghua Li et al. Science Immunology
- SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation
- (2021) Lucy G Thorne et al. EMBO JOURNAL
- SARS‐CoV‐2 nucleocapsid suppresses host pyroptosis by blocking Gasdermin D cleavage
- (2021) Juan Ma et al. EMBO JOURNAL
- Long‐lived macrophage reprogramming drives spike protein‐mediated inflammasome activation in COVID‐19
- (2021) Sebastian J Theobald et al. EMBO Molecular Medicine
- Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19
- (2021) Roberto Caricchio et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Post-viral effects of COVID-19 in the olfactory system and their implications
- (2021) Michael S Xydakis et al. LANCET NEUROLOGY
- AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence
- (2021) SangJoon Lee et al. NATURE
- Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
- (2021) J. Loske et al. NATURE BIOTECHNOLOGY
- Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
- (2021) Evdoxia Kyriazopoulou et al. NATURE MEDICINE
- Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein
- (2021) Jack Chun-Chieh Hsu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block
- (2021) James M. Burke et al. RNA
- The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
- (2021) Rajendra Karki et al. TRENDS IN IMMUNOLOGY
- SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
- (2021) Pan Pan et al. Nature Communications
- New-onset IgG autoantibodies in hospitalized patients with COVID-19
- (2021) Sarah Esther Chang et al. Nature Communications
- Lower peripheral blood Toll-like receptor 3 expression is associated with an unfavorable outcome in severe COVID-19 patients
- (2021) Maria Clara Saad Menezes et al. Scientific Reports
- Intranasal type I interferon treatment is beneficial only when administered before clinical signs onset in the SARS-CoV-2 hamster model
- (2021) Pierre Bessière et al. PLoS Pathogens
- DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist
- (2021) Michel Thépaut et al. PLoS Pathogens
- RIG-I-Like Receptor-Mediated Recognition of Viral Genomic RNA of Severe Acute Respiratory Syndrome Coronavirus-2 and Viral Escape From the Host Innate Immune Responses
- (2021) Takahisa Kouwaki et al. Frontiers in Immunology
- CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2
- (2021) Razie Amraei et al. ACS Central Science
- Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells
- (2021) Huabin Ma et al. Cell Discovery
- Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
- (2021) Paul Bastard et al. Science Immunology
- X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
- (2021) Takaki Asano et al. Science Immunology
- TLR3 and TLR7 RNA Sensor Activation during SARS-COV-2 Infection
- (2021) Daria Bortolotti et al. Microorganisms
- Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial
- (2021) Ivan O. Rosas et al. INTENSIVE CARE MEDICINE
- X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia
- (2021) Hassan Abolhassani et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice
- (2021) Tianyang Mao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis
- (2021) Rajendra Karki et al. Cell Reports
- Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial
- (2021) Andre C Kalil et al. Lancet Respiratory Medicine
- Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice
- (2021) Jianxiong Zeng et al. EBioMedicine
- Toll-Like Receptor 4 Polymorphisms (896A/G and 1196C/T) as an Indicator of COVID-19 Severity in a Convenience Sample of Egyptian Patients
- (2021) Sara I Taha et al. Journal of Inflammation Research
- Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study)
- (2021) Aránzazu Sancho-López et al. Infectious Diseases and Therapy
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense
- (2020) Min Zheng et al. CELL
- Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19
- (2020) Annsea Park et al. Cell Host & Microbe
- Acute heart failure in multisystem inflammatory syndrome in children (MIS-C) in the context of global SARS-CoV-2 pandemic
- (2020) Zahra Belhadjer et al. CIRCULATION
- Immunology of COVID-19: current state of the science
- (2020) Nicolas Vabret et al. IMMUNITY
- Viropathic multinuclear syncytial giant cells in bronchial fluid from a patient with COVID-19
- (2020) Sylvia Stadlmann et al. JOURNAL OF CLINICAL PATHOLOGY
- NOD1 Promotes Antiviral Signaling by Binding Viral RNA and Regulating the Interaction of MDA5 and MAVS
- (2020) Xiao Man Wu et al. JOURNAL OF IMMUNOLOGY
- Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
- (2020) Zhaohai Zheng et al. JOURNAL OF INFECTION
- In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs
- (2020) Abhigyan Choudhury et al. JOURNAL OF MEDICAL VIROLOGY
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes
- (2020) Mario Adán Moreno-Eutimio et al. MICROBES AND INFECTION
- Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
- (2020) Mingfeng Liao et al. NATURE MEDICINE
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)
- (2020) Shelbi Christgen et al. Frontiers in Cellular and Infection Microbiology
- Presence of antiphospholipid antibodies in COVID-19: case series study
- (2020) Luis M Amezcua-Guerra et al. ANNALS OF THE RHEUMATIC DISEASES
- Severe COVID-19 is marked by a dysregulated myeloid cell compartment
- (2020) Jonas Schulte-Schrepping et al. CELL
- Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19
- (2020) Aymeric Silvin et al. CELL
- Retrospective Multicenter Cohort Study Shows Early Interferon Therapy Is Associated with Favorable Clinical Responses in COVID-19 Patients
- (2020) Nan Wang et al. Cell Host & Microbe
- Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis
- (2020) Jin-Wen Song et al. Cell Metabolism
- The ORF3a protein of SARS-CoV-2 induces apoptosis in cells
- (2020) Yujie Ren et al. Cellular & Molecular Immunology
- Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients
- (2020) Linnan Zhu et al. IMMUNITY
- Presence of Genetic Variants Among Young Men With Severe COVID-19
- (2020) Caspar I. van der Made et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Impaired NLRP3 inflammasome activation/pyroptosis leads to robust inflammatory cell death via caspase-8/RIPK3 during coronavirus infection
- (2020) Min Zheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
- (2020) Matthias Thoms et al. SCIENCE
- Type I and III interferons disrupt lung epithelial repair during recovery from viral infection
- (2020) Jack Major et al. SCIENCE
- Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm
- (2020) Chuang Guo et al. Nature Communications
- Biological sex impacts COVID-19 outcomes
- (2020) Sabra L. Klein et al. PLoS Pathogens
- Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer
- (2020) Rajendra Karki et al. JCI Insight
- Clinical and pathological investigation of patients with severe COVID-19
- (2020) Shaohua Li et al. JCI Insight
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
- (2020) Naoki Kaneko et al. CELL
- Syncytia formation by SARS‐CoV‐2 infected cells
- (2020) Julian Buchrieser et al. EMBO JOURNAL
- Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV-2
- (2020) Caroline Diorio et al. JOURNAL OF CLINICAL INVESTIGATION
- A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
- (2020) Kenneth H. Dinnon et al. NATURE
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
- (2020) Luca Perico et al. Nature Reviews Nephrology
- SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling
- (2020) Lisa Miorin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines
- (2020) SangJoon Lee et al. TRENDS IN IMMUNOLOGY
- The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway
- (2020) Jin-Yan Li et al. VIRUS RESEARCH
- Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome
- (2020) Maria Orietta Borghi et al. Frontiers in Immunology
- Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
- (2020) Rajendra Karki et al. CELL
- Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study
- (2020) Daniele Generali et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis)
- (2020) Balaji Banoth et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
- (2020) Tamara S. Rodrigues et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genetic mechanisms of critical illness in Covid-19
- (2020) Erola Pairo-Castineira et al. NATURE
- Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison
- (2020) Ioanna-Evdokia Galani et al. NATURE IMMUNOLOGY
- Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
- (2020) Andre C. Kalil et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
- (2020) Carlos Salama et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production
- (2020) Keli Chen et al. Viruses-Basel
- SARS-CoV-2 Spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity
- (2020) Ganna Petruk et al. Journal of Molecular Cell Biology
- Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model
- (2020) Pamela C. Proud et al. EBioMedicine
- Detection of viruses by inflammasomes
- (2020) Lotte Spel et al. Current Opinion in Virology
- Envelope Protein Glycosylation Mediates Zika Virus Pathogenesis
- (2019) Derek L. Carbaugh et al. JOURNAL OF VIROLOGY
- Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation
- (2019) Corey Rogers et al. Nature Communications
- Inflammasomes and the fine line between defense and disease
- (2019) Shelbi Christgen et al. CURRENT OPINION IN IMMUNOLOGY
- Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity–independent pyroptosis, apoptosis, necroptosis, and inflammatory disease
- (2019) R.K. Subbarao Malireddi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- STING-dependent translation inhibition restricts RNA virus replication
- (2018) Kate M. Franz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dengue virus activates cGAS through the release of mitochondrial DNA
- (2017) Bo Sun et al. Scientific Reports
- An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells
- (2016) Ivan Zanoni et al. SCIENCE
- Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection
- (2015) Allison L. Totura et al. mBio
- Dietary modulation of the microbiome affects autoinflammatory disease
- (2014) John R. Lukens et al. NATURE
- Activated STING in a Vascular and Pulmonary Syndrome
- (2014) Yin Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toll-Like Receptor 1 Polymorphisms and Associated Outcomes in Sepsis After Traumatic Injury
- (2013) Callie M. Thompson et al. ANNALS OF SURGERY
- Signalling C-Type lectin receptors, microbial recognition and immunity
- (2013) J. Claire Hoving et al. CELLULAR MICROBIOLOGY
- Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity
- (2013) John W. Schoggins et al. NATURE
- 5,6-Dimethylxanthenone-4-acetic Acid (DMXAA) Activates Stimulator of Interferon Gene (STING)-dependent Innate Immune Pathways and Is Regulated by Mitochondrial Membrane Potential
- (2012) Daniel Prantner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Intranasal Treatment with Poly(I{middle dot}C) Protects Aged Mice from Lethal Respiratory Virus Infections
- (2012) J. Zhao et al. JOURNAL OF VIROLOGY
- Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
- (2012) L. Sun et al. SCIENCE
- Immune Signaling by RIG-I-like Receptors
- (2011) Yueh-Ming Loo et al. IMMUNITY
- Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus
- (2011) S. M. Horner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1β and caspase-1 in monocytes and dendritic cells
- (2009) Julia Hurst et al. IMMUNOBIOLOGY
- Human antiphospholipid antibodies induce TNFα in monocytes via Toll-like receptor 8
- (2009) Yvonne Döring et al. IMMUNOBIOLOGY
- TLR7 and TLR8 as targets in cancer therapy
- (2008) M P Schön et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation